CLINICAL APPLICATIONS
- Prostate cancer with biochemical recurrence, i.e. prostatic specific antigen (PSA) over 0.4 ng/ml.
- Response to treatment CaP.
References:
Afshar-Oromieh A, Haberkorn U, Eder M, Eisenhut C, Zech- mann. [(68)Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with (18) F-FECH. Eur J Nucl Med Mol Imaging 2012;39:1085–1086.